Cargando…
Diagnostic and prognostic significance of SLC50A1 expression in patients with primary early breast cancer
There is a lack of validated biomarkers for the diagnosis of early breast cancer (EBC). The current study aimed to determine the diagnostic and prognostic value of solute carrier family 50 member 1 (SLC50A1) in patients with EBC. Therefore, 123 patients with EBC, 30 patients with benign breast disea...
Autores principales: | Zhang, Qunchen, Fang, Yutong, She, Chuanghong, Zheng, Rongji, Hong, Chaoqun, Chen, Chunfa, Wu, Jundong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468843/ https://www.ncbi.nlm.nih.gov/pubmed/36160901 http://dx.doi.org/10.3892/etm.2022.11553 |
Ejemplares similares
-
Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates
por: Fang, Yutong, et al.
Publicado: (2022) -
Identification and comprehensive analysis of epithelial–mesenchymal transition related target genes of miR-222-3p in breast cancer
por: Fang, Yutong, et al.
Publicado: (2023) -
The novel sugar transporter SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer
por: Wang, Yu, et al.
Publicado: (2019) -
Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer
por: Liu, Limei, et al.
Publicado: (2020) -
Quantitative Analysis and Diagnostic Significance of Methylated SLC19A3 DNA in the Plasma of Breast and Gastric Cancer Patients
por: Ng, Enders K. O., et al.
Publicado: (2011)